Neuphoria Therapeutics Inc. (NEUP)
NEUP Stock Price Chart
Explore Neuphoria Therapeutics Inc. interactive price chart. Choose custom timeframes to analyze NEUP price movements and trends.
NEUP Company Profile
Discover essential business fundamentals and corporate details for Neuphoria Therapeutics Inc. (NEUP) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
16 Dec 2021
Employees
8.00
Website
http://www.neuphoriatx.comCEO
Spyridon Papapetropoulos
Description
Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing treatments through clinical trials. Its core mission involves pioneering therapies specifically engineered to address the intricate requirements of individuals living with neuropsychiatric disorders. The company was established on December 23, 2024, and its main corporate offices are located in Burlington, Massachusetts.
NEUP Financial Timeline
Browse a chronological timeline of Neuphoria Therapeutics Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 Oct 2026
EPS estimate is -$0.56.
Upcoming earnings on 2 Sept 2026
EPS estimate is -$0.56.
Earnings released on 15 May 2026
EPS came in at -$0.09 surpassing the estimated -$0.56 by +83.93%.
Earnings released on 17 Feb 2026
EPS came in at -$0.77 falling short of the estimated -$0.56 by -37.50%.
Earnings released on 14 Nov 2025
EPS came in at -$4.41 falling short of the estimated -$0.55 by -701.82%.
Earnings released on 29 Sept 2025
EPS came in at -$5.79 falling short of the estimated -$0.56 by -933.93%, while revenue for the quarter reached -$15.66m , missing expectations by -6.03k%.
Earnings released on 20 May 2025
EPS came in at $6.55 surpassing the estimated -$0.47 by +1.49k%, while revenue for the quarter reached $15.00m , beating expectations by +5.58k%.
Earnings released on 17 Mar 2025
EPS came in at -$0.01 surpassing the estimated -$2.01 by +99.59%, while revenue for the quarter reached $662.60k , beating expectations by +150.70%.
Stock split effective on 24 Dec 2024
Shares were split 1 : 12 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 15 Nov 2024
EPS came in at -$0.00 .
Earnings released on 30 Sept 2024
EPS came in at -$29.16 falling short of the estimated -$11.38 by -156.21%.
Earnings released on 31 Mar 2024
EPS came in at -$0.02 , while revenue for the quarter reached -$79.00k .
Earnings released on 31 Dec 2023
EPS came in at -$0.03 .
Earnings released on 30 Sept 2023
EPS came in at -$0.01 surpassing the estimated -$13.44 by +99.96%, while revenue for the quarter reached $5.48m , beating expectations by +74.48%.
Earnings released on 23 Feb 2023
EPS came in at -$17.65 falling short of the estimated -$15.30 by -15.30%, while revenue for the quarter reached $214.74k , missing expectations by -92.59%.
Earnings released on 25 Aug 2022
EPS came in at -$13.84 surpassing the estimated -$15.35 by +9.84%, while revenue for the quarter reached $29.75k , beating expectations by +108.54%.
Earnings released on 23 Feb 2022
EPS came in at -$20.33 falling short of the estimated -$8.76 by -132.12%.
Earnings released on 25 Aug 2021
NEUP Stock Performance
Access detailed NEUP performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
